Sexual Dysfunction

Research suggests potential gaps in ED care delivered by nonurologists

October 16, 2020

Men who receive care for erectile dysfunction from their primary care provider are much less likely to receive advanced pharmacological therapies for management of their condition than those treated by urologists.

Sexual dysfunction: Protocol decreases opioid requirements in IPP patients

July 20, 2018

The AUA 2018 sexual dysfunction take-home messages also included a novel end-to-side nerve grafting procedure for men with post-radical-prostatectomy ED as well as the finding that use of a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor does not appear to change the adverse effect profile of flibanserin (Addyi).

AUA ’18: Experts pick this year’s key research

May 08, 2018

To help you sift the enormous scientific program and prioritize your schedule at the AUA annual meeting, the editors have called upon Urology Times’ editorial advisory board to identify the key research across multiple areas of the specialty.

Streamlined management of Peyronie’s disease

February 01, 2018

In this article, we describe our thought processes in treating patients with Peyronie's disease, which are summarized in an algorithm.

Penile transplant guidelines missing in action

January 01, 2018

There are no national or international guidelines regarding penile transplants, raising a question without a concrete answer: What are the rules and the limits?

Progress on penile transplant moves forward

January 01, 2018

"[Penile transplantation] is a real advance for patients who have a penile deficiency or penile loss," says Arthur L. Burnett, II, MD, MBA.

Survey: Urologists lack knowledge, training in transgender care

November 20, 2017

While urologists are generally comfortable discussing patients’ sexual orientation, they report that both their knowledge of care of transgender patients and training in such care are lacking.

Shock waves may change future of ED therapy

November 17, 2017

It’s hard to argue against an erectile dysfunction treatment that is potentially disease modifying, is noninvasive, and seems to do no harm. The treatment, low-intensity shock wave therapy, has yet to earn the FDA’s approval but is widely used in other countries. Early results from ongoing U.S. trials are promising.

New Products: FDA approves treatment for complicated UTI

October 11, 2017

Other products and services discussed in this round-up include a biosimilar for cancer, an American College of Surgeons manual on quality initiatives, a kidney cancer microsite, and more.

Uro Pipeline: Supplemental application submitted for advanced RCC treatment

August 15, 2017

Other pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.

New products: Holmium laser increases stone ablation volume

July 14, 2017

Other products discussed include cancer tests, an app to connect patients with specialists, a revenue management system, and more

Uro Pipeline: Phase IIb study begins for intraprostatic localized PCa drug

June 27, 2017

Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.

Study: Consumer ads prompt men to seek TRT

May 04, 2017

Findings of an ecologic study indicate that direct-to-consumer advertising for testosterone therapy influenced men to seek treatment and was accompanied by increased testosterone prescribing, including initiation in men without clear indications for use.

Transgender surgery: Videos demonstrate cutting-edge techniques

April 06, 2017

In these videos, expert surgeons demonstrate robot-assisted penile inversion vaginoplasty, single-stage metoidioplasty, and simple orchiectomy for transgender patients.